An Unusual Combination: KRAS and BRAF Co-mutated Metastatic Colorectal Cancer

被引：0
|
作者：
Epperla N. [1 ]
George B. [1 ]
机构：
[1] Department of Hematology and Oncology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI
来源：
Journal of Gastrointestinal Cancer | 2016年 / 47卷 / 2期
关键词：
Positron Emission Tomography; Bevacizumab; Standardize Uptake Value; Lynch Syndrome; KRAS Mutation;
D O I：
10.1007/s12029-015-9735-y
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：206 / 209
页数：3
相关论文
共 50 条
  • [21] Phase II study of linifanib in KRAS mutated metastatic refractory colorectal cancer
    Chan, E.
    Ayers, G. D.
    Goff, L.
    McClanahan, P.
    Holloway, M.
    Ciombor, K.
    Smith, S. J.
    Ancell, K.
    Cardin, D. B.
    Berlin, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S549 - S549
  • [22] Lung metastasis as predictor for prognosis in metastatic colorectal cancer with mutated KRAS.
    Boursi, Ben
    Shacham-Shmueli, Einat
    Lawrence, Yaacov Richard
    Yang, Yu-Xiao
    Reiss, Kim Anna
    Golan, Talia
    Mamtani, Raashi
    Halpern, Naama
    Aderka, Dan
    Giantonio, Bruce
    Margalit, Ofer
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [23] The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer
    Fanelli, Giuseppe Nicolo
    Dal Pozzo, Carlo Alberto
    Depetris, Ilaria
    Schirripa, Marta
    Brignola, Stefano
    Biason, Paola
    Balistreri, Mariangela
    Dal Santo, Luca
    Lonardi, Sara
    Munari, Giada
    Loupakis, Fotios
    Fassan, Matteo
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [24] Progression-free survival in metastatic, BRAF-mutated colorectal cancer
    Morris, Van Karlyle
    Overman, Michael J.
    Maru, Dipen M.
    Kopetz, Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [25] Lung Metastasis Predicts Better Prognosis in Metastatic Colorectal Cancer With Mutated KRAS
    Margalit, Ofer
    Shacham-Shmueli, Einat
    Lawrence, Yaacov R.
    Yang, Yu-Xiao
    Reiss, Kim A.
    Golan, Talia
    Mamtani, Raashi
    Halpern, Naama
    Aderka, Dan
    Giantonio, Bruce
    Boursi, Ben
    CLINICAL COLORECTAL CANCER, 2019, 18 (03) : E300 - E307
  • [26] QUANTITATIVE MEASUREMENT OF KRAS MUTATED ALLELES IN PLASMA AS PROGNOSTIC MARKER IN METASTATIC KRAS MUTANT COLORECTAL CANCER
    Spindler, K.
    Pallisgaard, N.
    Andersen, R.
    Jakobsen, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 530 - 531
  • [27] BRAF V600E-mutated Colorectal Neuroendocrine Carcinoma Effectively Treated with a Chemotherapy Protocol for BRAF-mutated Metastatic Colorectal Cancer
    Owaki, Seira
    Mori, Yoshinori
    Nakai, Shunsuke
    Maeda, Hideki
    Imazu, Mitsuki
    Tomita, Yusaku
    Kanaiwa, Hiroki
    Yamaguchi, Ayana
    Kitagawa, Mika
    Hirano, Atsuyuki
    Kimura, Yoshihide
    Tsuchida, Kenji
    Kataoka, Hiromi
    INTERNAL MEDICINE, 2024, 63 (14) : 1995 - 1999
  • [28] MicroRNA Expression in KRAS- and BRAF-mutated Colorectal Cancers
    Lundberg, Ida V.
    Wikberg, Maria L.
    Ljuslinder, Ingrid
    Li, Xingru
    Myte, Robin
    Zingmark, Carl
    Lofgren-Burstrom, Anna
    Edin, Sofia
    Palmqvist, Richard
    ANTICANCER RESEARCH, 2018, 38 (02) : 677 - 683
  • [29] KRAS, BRAF and PIK3CA mutations in human colorectal cancer: Relationship with metastatic colorectal cancer
    Li, Hong-Tao
    Lu, Yuan-Yuan
    An, Yan-Xin
    Wang, Xin
    Zhao, Qing-Chuan
    ONCOLOGY REPORTS, 2011, 25 (06) : 1691 - 1697
  • [30] A STING operation to expose KRAS and STK11 co-mutated lung cancers
    Skoulidis, Ferdinandos
    V. Heymach, John
    Cascone, Tina
    CANCER CELL, 2022, 40 (10) : 1073 - 1076
12345